PharmaCyte Biotech's Improved Technology Attracting World Class Oncologists
July 30, 2015 09:00 ET
|
PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - July 30, 2015) - PharmaCyte Biotech (OTCQB: PMCB) is a small international biotechnology firm, but you wouldn't know it by the company it keeps. How does PharmaCyte keep...
PharmaCyte Biotech's Cell-in-a-Box Technology Makes Good Cancer Drugs Better
July 13, 2015 09:00 ET
|
PharmaCyte Biotech, Inc.
BONITA, CA--(Marketwired - July 13, 2015) - While many biotech companies are working on new oncology drugs, what's often unappreciated about cancer treatments is how a key improvement in the way drugs...
PharmaCyte Biotech Creates Faster Path to the Clinic for Company's Diabetes Treatment
May 20, 2015 09:30 ET
|
PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - May 20, 2015) - PharmaCyte Biotech (OTCQB: PMCB) has managed to do something that is rarely done in science -- bring together an international group of leading experts to...
Breakthrough Diabetes Research to Be Commercialized by US-Based Nuvilex, Inc.
November 03, 2014 10:49 ET
|
Nuvilex, Inc.
SYDNEY, AUSTRALIA--(Marketwired - November 03, 2014) - Australian research that has produced a line of insulin producing cells that could eliminate the need for injections for Type 1 diabetics will be...
Nuvilex, Inc. Moves Closer to "Bio-Artificial Pancreas" Diabetes Treatment With License for Insulin-Producing Cells
October 21, 2014 09:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - October 21, 2014) - Nuvilex, Inc. (OTCQB: NVLX) has carefully mapped out its plan to develop a diabetes treatment using the Cell-in-a-Box®
platform technology. It started...
New center at Kosair Children's Hospital will help transform lives of children with diabetes
November 14, 2013 16:01 ET
|
Norton Healthcare
LOUISVILLE, KY., Nov. 14, 2013 (GLOBE NEWSWIRE) -- The Wendy L. Novak Diabetes Care Center at Kosair Children's Hospital has opened, offering children with Type 1 diabetes access to advanced treatment...
PositiveID Corporation Finalizes First-in-Class Development of a Fully Synthetic Glucose Sensing System, a Critical Component of an Artificial Pancreas
March 05, 2012 08:00 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., March 5, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today that it has...
New Diabetes Study by Cutting Edge Information Examines Drugs, Classes, and Market Leaders
January 06, 2010 09:18 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - January 6, 2010) - Cutting Edge Information (CEI)
announces the release of its newest diabetes market forecast...